Crohn’s Disease Diagnostic and Therapeutic Market, Global Outlook and Forecast 2022-2028

April 2022 | 67 pages | ID: CA491A6AF636EN
Market Monitor Global

Abstracts

Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals.

This report contains market size and forecasts of Crohn’s Disease Diagnostic and Therapeutic in Global, including the following market information:

Global Crohn’s Disease Diagnostic and Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Crohn’s Disease Diagnostic and Therapeutic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Diagnostics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Crohn’s Disease Diagnostic and Therapeutic include Abbvie, Celgene, Genetech, Johnson & Johnson, Pfizer, Prometheus Laboratories, Salix Pharmaceuticals and Takeda Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Crohn’s Disease Diagnostic and Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Crohn’s Disease Diagnostic and Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Crohn’s Disease Diagnostic and Therapeutic Market Segment Percentages, by Type, 2021 (%)

• Diagnostics
• Treatment

Global Crohn’s Disease Diagnostic and Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Crohn’s Disease Diagnostic and Therapeutic Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Medical Research Institute
• Other

Global Crohn’s Disease Diagnostic and Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Crohn’s Disease Diagnostic and Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Crohn’s Disease Diagnostic and Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Crohn’s Disease Diagnostic and Therapeutic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbvie
• Celgene
• Genetech
• Johnson & Johnson
• Pfizer
• Prometheus Laboratories
• Salix Pharmaceuticals
• Takeda Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Crohn’s Disease Diagnostic and Therapeutic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Crohn’s Disease Diagnostic and Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CROHN’S DISEASE DIAGNOSTIC AND THERAPEUTIC OVERALL MARKET SIZE

2.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size: 2021 VS 2028
2.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Crohn’s Disease Diagnostic and Therapeutic Players in Global Market
3.2 Top Global Crohn’s Disease Diagnostic and Therapeutic Companies Ranked by Revenue
3.3 Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Crohn’s Disease Diagnostic and Therapeutic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Crohn’s Disease Diagnostic and Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Crohn’s Disease Diagnostic and Therapeutic Players in Global Market
  3.6.1 List of Global Tier 1 Crohn’s Disease Diagnostic and Therapeutic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Crohn’s Disease Diagnostic and Therapeutic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Crohn’s Disease Diagnostic and Therapeutic Market Size Markets, 2021 & 2028
  4.1.2 Diagnostics
  4.1.3 Treatment
4.2 By Type - Global Crohn’s Disease Diagnostic and Therapeutic Revenue & Forecasts
  4.2.1 By Type - Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2022
  4.2.2 By Type - Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2023-2028
  4.2.3 By Type - Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Crohn’s Disease Diagnostic and Therapeutic Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Medical Research Institute
  5.1.4 Other
5.2 By Application - Global Crohn’s Disease Diagnostic and Therapeutic Revenue & Forecasts
  5.2.1 By Application - Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2022
  5.2.2 By Application - Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2023-2028
  5.2.3 By Application - Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Crohn’s Disease Diagnostic and Therapeutic Market Size, 2021 & 2028
6.2 By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue & Forecasts
  6.2.1 By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2022
  6.2.2 By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2023-2028
  6.2.3 By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2028
  6.3.2 US Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.3.3 Canada Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.3.4 Mexico Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2028
  6.4.2 Germany Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.4.3 France Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.4.4 U.K. Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.4.5 Italy Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.4.6 Russia Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.4.7 Nordic Countries Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.4.8 Benelux Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2028
  6.5.2 China Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.5.3 Japan Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.5.4 South Korea Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.5.5 Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.5.6 India Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2028
  6.6.2 Brazil Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.6.3 Argentina Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2028
  6.7.2 Turkey Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.7.3 Israel Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.7.4 Saudi Arabia Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028
  6.7.5 UAE Crohn’s Disease Diagnostic and Therapeutic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbvie
  7.1.1 Abbvie Corporate Summary
  7.1.2 Abbvie Business Overview
  7.1.3 Abbvie Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
  7.1.4 Abbvie Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
  7.1.5 Abbvie Key News
7.2 Celgene
  7.2.1 Celgene Corporate Summary
  7.2.2 Celgene Business Overview
  7.2.3 Celgene Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
  7.2.4 Celgene Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
  7.2.5 Celgene Key News
7.3 Genetech
  7.3.1 Genetech Corporate Summary
  7.3.2 Genetech Business Overview
  7.3.3 Genetech Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
  7.3.4 Genetech Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
  7.3.5 Genetech Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
  7.4.4 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
  7.5.4 Pfizer Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Prometheus Laboratories
  7.6.1 Prometheus Laboratories Corporate Summary
  7.6.2 Prometheus Laboratories Business Overview
  7.6.3 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
  7.6.4 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
  7.6.5 Prometheus Laboratories Key News
7.7 Salix Pharmaceuticals
  7.7.1 Salix Pharmaceuticals Corporate Summary
  7.7.2 Salix Pharmaceuticals Business Overview
  7.7.3 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
  7.7.4 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
  7.7.5 Salix Pharmaceuticals Key News
7.8 Takeda Pharmaceutical
  7.8.1 Takeda Pharmaceutical Corporate Summary
  7.8.2 Takeda Pharmaceutical Business Overview
  7.8.3 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Major Product Offerings
  7.8.4 Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Revenue in Global Market (2017-2022)
  7.8.5 Takeda Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Crohn’s Disease Diagnostic and Therapeutic Market Opportunities & Trends in Global Market
Table 2. Crohn’s Disease Diagnostic and Therapeutic Market Drivers in Global Market
Table 3. Crohn’s Disease Diagnostic and Therapeutic Market Restraints in Global Market
Table 4. Key Players of Crohn’s Disease Diagnostic and Therapeutic in Global Market
Table 5. Top Crohn’s Disease Diagnostic and Therapeutic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Crohn’s Disease Diagnostic and Therapeutic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Crohn’s Disease Diagnostic and Therapeutic Product Type
Table 9. List of Global Tier 1 Crohn’s Disease Diagnostic and Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Crohn’s Disease Diagnostic and Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Crohn’s Disease Diagnostic and Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Crohn’s Disease Diagnostic and Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Crohn’s Disease Diagnostic and Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Crohn’s Disease Diagnostic and Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2023-2028
Table 30. Abbvie Corporate Summary
Table 31. Abbvie Crohn’s Disease Diagnostic and Therapeutic Product Offerings
Table 32. Abbvie Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corporate Summary
Table 34. Celgene Crohn’s Disease Diagnostic and Therapeutic Product Offerings
Table 35. Celgene Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
Table 36. Genetech Corporate Summary
Table 37. Genetech Crohn’s Disease Diagnostic and Therapeutic Product Offerings
Table 38. Genetech Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Product Offerings
Table 41. Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Crohn’s Disease Diagnostic and Therapeutic Product Offerings
Table 44. Pfizer Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
Table 45. Prometheus Laboratories Corporate Summary
Table 46. Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Product Offerings
Table 47. Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
Table 48. Salix Pharmaceuticals Corporate Summary
Table 49. Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Product Offerings
Table 50. Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)
Table 51. Takeda Pharmaceutical Corporate Summary
Table 52. Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Product Offerings
Table 53. Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Crohn’s Disease Diagnostic and Therapeutic Segment by Type in 2021
Figure 2. Crohn’s Disease Diagnostic and Therapeutic Segment by Application in 2021
Figure 3. Global Crohn’s Disease Diagnostic and Therapeutic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Crohn’s Disease Diagnostic and Therapeutic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Crohn’s Disease Diagnostic and Therapeutic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Crohn’s Disease Diagnostic and Therapeutic Revenue in 2021
Figure 8. By Type - Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
Figure 12. US Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
Figure 16. Germany Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 17. France Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
Figure 24. China Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 28. India Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
Figure 30. Brazil Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share, 2017-2028
Figure 33. Turkey Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Crohn’s Disease Diagnostic and Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 37. Abbvie Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Genetech Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Takeda Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)